Soleno Therapeutics announced the appointment of Matthew Pauls, J.D., M.B.A, to its Board of Directors, effective August 15, 2023. Since 2020, Mr. Pauls has served as Chair of the Board of Directors and Chief Executive Officer of Savara, Inc., a biopharmaceutical company focused on rare respiratory diseases.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SLNO:
- Soleno Therapeutics reports Q2 EPS (81c), consensus (83c)
- SLNO Upcoming Earnings Report: What to Expect?
- Soleno Therapeutics to participate in a conference call with Cantor Fitzgerald
- Soleno Therapeutics files to sell 22.6M shares of common stock for holders
- Soleno Therapeutics management to meet virtually with Oppenheimer